[HTML][HTML] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong, Y Jin… - BMC cardiovascular …, 2020 - Springer
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
[PDF][PDF] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong, Y Jin… - 2020 - scholar.archive.org
Background: Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
[HTML][HTML] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang… - BMC …, 2020 - bmccardiovascdisord.biomedcentral …
Statin remains a mainstay in the prevention and treatment of cardiovascular diseases. Statin
utilization has evolved over time in many countries, but data on this topic from China are …
utilization has evolved over time in many countries, but data on this topic from China are …
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong, Y Jin… - 2020 - cabidigitallibrary.org
Background: Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
[HTML][HTML] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong… - BMC Cardiovascular …, 2020 - ncbi.nlm.nih.gov
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong… - BMC Cardiovascular …, 2020 - go.gale.com
Background The incidence of cardiovascular diseases (CVD) continues to rise and has
become the leading cause of mortality (responsible for above 40% of all deaths) in China in …
become the leading cause of mortality (responsible for above 40% of all deaths) in China in …
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren… - BMC …, 2020 - search.proquest.com
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong… - BMC Cardiovascular …, 2020 - europepmc.org
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
[PDF][PDF] Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital …
Y Liu, X Lv, N Xie, Z Fang, W Ren, Y Gong, Y Jin… - 2020 - bmccardiovascdisord.biomedcentral …
Background: Statin remains a mainstay in the prevention and treatment of cardiovascular
diseases. Statin utilization has evolved over time in many countries, but data on this topic …
diseases. Statin utilization has evolved over time in many countries, but data on this topic …